During the past decade, Haematologisch-Onkologische Praxis Altona conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haematologisch-Onkologische Praxis Altona" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "III. Medizinische Klinik Mannheim" with 1 trials sponsored and "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haematologisch-Onkologische Praxis Altona" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Clinical Trial Center North (CTC North GmbH & Co. KG)" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Servier Affaires Médicales" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Haematologisch-Onkologische Praxis Altona" are "Melanoma (Skin)" (5 trials), "Lymphoma" (4 trials), "Breast Cancer" (2 trials), "Adenocarcinoma of the Stomach" (1 trials) and "Advanced Solid Tumors or Hematologic Malignancies" (1 trials). Many other conditions were trialed in "Haematologisch-Onkologische Praxis Altona" in a lesser frequency.

Most popular intervention types in "Haematologisch-Onkologische Praxis Altona" are "Drug" (14 trials), "Biological" (9 trials), "Radiation" (5 trials), "Procedure" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "radiation therapy" (5 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Haematologisch-Onkologische Praxis Altona" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Haematologisch-Onkologische Praxis Altona". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Haematologisch-Onkologische Praxis Altona, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Haematologisch-Onkologische Praxis Altona, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".